Home › Calculator › OPORF Dividend Calculator 2026
OPORF Dividend DRIP Calculator 2026
2.47% YieldHealthcarehVIVO plc · OTC
Price: $0.11 · Annual div: $0.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When OPORF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your OPORF snowball 📈
$10,000 in OPORF → $9.79M in 10 years · $21.07/month
About hVIVO plc (OPORF) — Dividend Analysis 2026
hVIVO plc functions as a contract research organization and pharmaceutical service provider, primarily dedicated to evaluating vaccines and antiviral medications. This is achieved through specialized human challenge clinical trials. The company extends its services to a varied clientele, encompassing major pharmaceutical and biotechnology firms, governmental bodies, and public health agencies. A significant aspect of its operations is a comprehensive array of human challenge study models. These cover conditions such as respiratory syncytial virus (RSV), influenza, human rhinovirus, asthma, malaria, chronic cough, and chronic obstructive pulmonary disease (COPD), with a COVID-19 model currently being developed. Additionally, hVIVO is constructing the 'Disease in Motion' platform, an extensive database focused on infectious disease progression. This platform uniquely integrates diverse datasets, including clinical, immunological, virological, and digital (wearable) biomarkers. The 'Disease in Motion' platform holds broad potential applications for various end-users, from large technology and wearables companies to pharmaceutical and biotech sectors. Further capabilities include offering pre-clinical and early clinical research services, sales and marketing support, and expertise in biometry, data management, and statistics to its European pharmaceutical clients. The company also delivers drug development consultancy, covering Chemistry, Manufacturing, and Controls (CMC), pharmacokinetics (PK), and medical writing for a range of European clients. Formerly known as Open Orphan Plc, the company changed its name to hVIVO plc in October 2022 and is headquartered in London, United Kingdom.
Compare OPORF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full OPORF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open OPORF position with:
🌍 OPORF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold OPORF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.47% | -0.33% | $247 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.10% | -0.70% | $210 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.98% | -0.82% | $198 / yr |
| 🇬🇧 UK ISA | 0% | 2.47% | -0.33% | $247 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.25% | -0.55% | $225 / yr |
| 🇨🇦 TFSA | 0% | 2.47% | -0.33% | $247 / yr |
| 🇨🇦 CA Taxable | 25% | 1.85% | -0.95% | $185 / yr |
| 🇦🇺 Super (pension) | 15% | 2.10% | -0.70% | $210 / yr |
| 🇦🇺 AU Taxable | 30% | 1.73% | -1.07% | $173 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.82% | -0.98% | $182 / yr |
| 🇫🇷 FR Taxable | 30% | 1.73% | -1.07% | $173 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 OPORF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 OPORF Dividend Payment Schedule
OPORF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 OPORF vs Healthcare Benchmarks
How OPORF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for OPORF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ OPORF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the OPORF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
hVIVO plc (OPORF) is currently trading at $0.11, 80% below its 52-week high. The current dividend yield is 2.47% based on an annual payout of $0.00 per share.
OPORF (hVIVO plc) — 2.47% Dividend Yield Analysis
hVIVO plc (OPORF) is a healthcare stock currently trading at $0.11 with a dividend yield of 2.47%. The company pays an annual dividend of $0.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.